The Effect of Dextroamphetamine on Attention, Mood and Functional Recovery in Acute Traumatic Brain Injury: A Randomized, Placebo-Controlled Pilot Study
Principal Investigator Name
John Whyte, MD, Ph.D. & Thomas Watanabe, M.D.
Principal Investigator Email
This project is a placebo-controlled pilot study of the effects of dextroamphetamine (DEX) on attention, engagement in therapy, cognitive and motor speed, and other outcomes in subacute TBI. We will also examine the possibility that DEX accelerates the pace of functional recovery in the subacute phase.